• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

6,386
2,302
1,861
1,855
1,725

COUNTRY

868
652
272
254
210

CATEGORIES

  • 858
  • 186
  • 679
  • 1,127
  • 398
  • 270
  • 255
  • 66
  • 380
  • 725
  • 1,339
  • 1,355
  • 625
  • 884
  • 1,706
  • 2,683
  • 507
  • 732
  • 0
  • 93

PRICE

7,272
12,466
19,758
26,065

PUBLISHED

2,513
3,385
8,020
26,065

PRODUCT TYPE

21,188
2,901
872
827
164
44
21
21
20
6
1

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE

Breast Cancer Screening (Mammography, MRI & Ultrasound) Market & Forecast – Worldwide

Breast cancer is the most common cancer among women in both the developed and developing world. Worldwide Breast Cancer Screening Market was in double digit Billion US$ for 2013. United States is the...

September 2014
FROM
Alzheimer's Disease Drug Pipeline, Diagnostics and Biomarkers: New Developments, Growth Areas and Opportunities Alzheimer's Disease Drug Pipeline, Diagnostics and Biomarkers:  New Developments, Growth Areas and Opportunities - Product Thumbnail Image

Alzheimer's Disease Drug Pipeline, Diagnostics and Biomarkers: New Developments, Growth Areas and Opportunities

This report is a comprehensive analysis and market study of the drug development pipeline relating to Alzheimer's Disease, which has been analysed alongside commercially available or developmental minimally-invasive...

September 2014
FROM
Cancer Diagnostics: New Developments, Market Growth and Opportunities in the use of Circulating Tumour Cells and Circulating Nucleic Acids Cancer Diagnostics: New Developments, Market Growth and Opportunities in the use of Circulating Tumour Cells and Circulating Nucleic Acids - Product Thumbnail Image

Cancer Diagnostics: New Developments, Market Growth and Opportunities in the use of Circulating Tumour Cells and Circulating Nucleic Acids

The isolation and characterisation of CTCs and CNAs are two of the fastest growing areas of research in the cancer field. Growth is also being seen in the translation of this research into diagnostic...

September 2014
FROM

The European Markets For PCR Technologies

Since its invention three decades ago, PCR has evolved to become one of the fundamental technology platforms in life sciences sector. The application segments of this platform are still expanding, driven...

September 2014
FROM
Testing Laboratories in the US Testing Laboratories in the US - Product Thumbnail Image

Testing Laboratories in the US

Brief Excerpt from Industry Overview Chapter: Companies in this industry provide engineering, quality control, and certification services in a variety of industries. Major companies include National...

September 2014

PCSK9 and Other Novel Hypercholesterolemia Drugs

Worldwide statistics indicate that there is a high cholesterol burden despite the presence of many cholesterol-lowering drugs in the market. Out of all the available options, statins have been ubiquitously...

September 2014
FROM

Romania Pharmaceutical Report - Q2, 2014

This report covers the market developments in Q2/2014 and the data available as of August 2014. Sales of pharmaceuticals rose by 5.7% y/y (4.9% y/y in EUR terms) to RON 3bn (EUR 679.8mn) in Q2/2014,...

September 2014
FROM

Turkey Pharmaceuticals and Healthcare Report Q4 2014

BMI View: Despite a challenging pricing and reimbursement situation compounded by currency uncertainty, BMI still believes the Turkish pharmaceutical market is attractive in the long term as higher...

September 2014

Singapore Pharmaceuticals and Healthcare Report Q4 2014

BMI View: While Singapore's small population will limit the pharmaceutical market's overall growth potential, the government's commitment to healthcare as well as the ageing population will boost consumption...

September 2014

Sweden Pharmaceuticals and Healthcare Report Q4 2014

BMI View: As Sweden's population grows older and demands for healthcare provision increase, the government is facing a concerning scenario of rapidly increasing expenditure on medical services. Restricting...

September 2014

Nigeria Pharmaceuticals and Healthcare Report Q4 2014

BMI View: Nigeria's economy is largely dependent on its Oil and Gas sector. The likelihood of further divestments by international oil companies from the sector creates a downside risk to increasing...

September 2014

Italy Pharmaceuticals and Healthcare Report Q4 2014

BMI View: The drop in public pharmaceutical expenditure in Italy in 2013 to a level below that of spending a decade ago does not bode well for prescription drugmakers, patients and pharmacies in the...

September 2014

Colombia Pharmaceuticals and Healthcare Report Q4 2014

BMI View: President Juan Manuel Santos' re-election in June has given him a strong mandate to continue the process of healthcare reform in Colombia. Although the Santos administration has been successful...

September 2014

New Zealand Pharmaceuticals and Healthcare Report Q4 2014

BMI View: Limited pharmaceutical reimbursement in New Zealand will remain a key issue for innovative pharmaceutical firms as the country seeks to maintain tight control over pharmaceutical spending....

September 2014

Cameroon Pharmaceuticals and Healthcare Report Q4 2014

BMI View: A combination of the adoption of different mobile health innovations, health-targeted foreign aid inflows and sustained infrastructure investment will continue to create opportunities for...

September 2014

Global Healthcare Information Systems Market 2014-2018

About Healthcare Information System A healthcare information system is an integrated system designed for capturing, storing, managing, and transmitting information related to the health of individuals....

September 2014
FROM

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - The Netherlands

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - The Netherlands Summary The publisher, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare,...

September 2014
FROM

Fundamentals of Health Care Financial Management. A Practical Guide to Fiscal Issues and Activities, 4th Edition. Jossey-Bass Public Health

Learn the essentials of finance theory and practice with the tools needed in day-to-day practice In this thoroughly revised and updated fourth edition of Fundamentals of Health Care Financial Management,...

September 2014
1 Year - U.S. Regulatory Reporter Newsletter for Addresses in Europe 1 Year - U.S. Regulatory Reporter Newsletter for Addresses in Europe - Product Thumbnail Image

1 Year - U.S. Regulatory Reporter Newsletter for Addresses in Europe

This publication, the U S Regulatory Reporter Newsletter, is a monthly newsletter providing regulatory information for the pharmaceutical, medical and allied industries...

September 2014
The Incidence and Prevalence Database: Global Incidence, Prevalence, Morbidity, Comorbidity, Cost Data, Symptoms and Many Other Health Issues for over 4,500 Diseases and Procedures The Incidence and Prevalence Database: Global Incidence, Prevalence, Morbidity, Comorbidity, Cost Data, Symptoms and Many Other Health Issues for over 4,500 Diseases and Procedures - Product Thumbnail Image

The Incidence and Prevalence Database: Global Incidence, Prevalence, Morbidity, Comorbidity, Cost Data, Symptoms and Many Other Health Issues for over 4,500 Diseases and Procedures

What is the Incidence and Prevalence Database (IPD)? - 4,500 diseases and procedures - Updated every 4 weeks - Every data citation attached to its original source - Research analyst service attached...

September 2014
Loading Indicator

Our Clients

Our clients' logos